Prospects for neuroprotective therapies in glaucoma: drug targets an
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchNeurologySafetyCBDTHCAnxietyAging Why This Matters Cannabinoid signaling, particularly through anandamide…
Gov. JB Pritzker signs hemp regulations into law, settling Illinois’ lengthy delta-8 debate for now
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCSafetyIndustryDosingCBD Why This Matters Illinois’ new hemp regulations establish clear legal…
Medical Cannabis for PTSD: Efficacy Review
✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Mental HealthResearchSafetyAgingAnxietySleepPain Why This Matters Clinicians treating older PTSD patients need evidence…
Kentucky Ends Out-of-State Medical Marijuana Importation
Kentucky medical marijuana program ends the practice of patients bringing cannabis from out of state. This shift improves access to regulated, tested products for patients. Clinicians should understand these changes to guide patient care effectively.
Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry …
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyPolicyResearchMental HealthSafetyPediatricsTHC Why This Matters Clinicians need to understand this evidence…
A large-scale cannabis study is launching in the canton of St. Gallen | blue News
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyHempCBDTHCIndustry Why This Matters This large-scale Swiss study will generate rigorous…
Swiss canton St. Gallen launches new large-scale cannabis study – SWI swissinfo.ch
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchHempSafetyMental HealthAnxietyNeurology Why This Matters Swiss large-scale cannabis studies provide…
Federal Science Agency Adds New Cannabis Compounds To Its Library Of ‘Chemical Fingerprints’
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchHempCBDTHCSafetyIndustryPolicy Why This Matters Understanding the chemical fingerprints of cannabis compounds…
Cannabis Flower Reimbursement: Bundestag Votes on Insurance Coverage Cuts
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchPainTHCCBDSafetyIndustry Why This Matters German policymakers are debating whether to eliminate insurance…
Cannabis firm High Tide climbs 21% on record Q2 revenue
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryMental HealthResearchPolicySafetyCBDTHC Why This Matters Clinicians treating psychiatric patients need robust…